Latest Regulatory Approvals News

Lake Resources has increased its Measured and Indicated lithium resource at the Kachi Project in Argentina to 8.2 million tonnes LCE, revealing higher-grade lithium zones and enhanced recovery technology. This update strengthens the project's economic outlook amid ongoing feasibility and environmental assessments.

EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.

Core Lithium's Restart Study for the Finniss Lithium Operation confirms a 20-year underground mine life with significant cost reductions and enhanced production capacity.

Tamboran Resources has finalized a US$15 million sale of 100,000 acres to Daly Waters Energy, retaining a dominant 1.9 million-acre position in the Beetaloo Basin and setting the stage for its Phase 2 gas development targeting Australia's East Coast market.

Tamboran Resources has raised US$55.4 million through a private placement to fund critical drilling activities in the Beetaloo Basin, aiming for first gas production by mid-2026.

Anteris Technologies Global Corp. reported a $21.9 million net loss for Q1 2025, driven by increased R&D spending as it scales manufacturing and prepares pivotal trials for its DurAVR Transcatheter Heart Valve. The company’s recent $80 million IPO proceeds are being deployed to support these efforts and repay debt.

Aristocrat Leisure Limited has announced an ordinary unfranked dividend of AUD 0.44 per share for the six months ending March 2025, with key dates set for May and July.

Highfield Resources has inked a non-binding letter of intent with Qinghai Salt Lake, a China Minmetals subsidiary, for a US$300 million equity investment aimed at fast-tracking its potash projects in Spain and Canada.

Ramelius Resources has obtained regulatory relief from ASIC, extending the deadline to make its takeover offer for Spartan Resources by an additional 31 days, a move that could influence the pace and outcome of the acquisition.

OM Holdings has agreed to sell its 26% interest in Ntsimbintle Mining to Exxaro Resources for US$101.4 million, marking a strategic shift to refocus capital on core operations while maintaining a commercial partnership.

Neuren Pharmaceuticals has received official FDA minutes confirming the primary endpoints for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, reinforcing the positive signals from earlier studies.

Peninsula Energy has received critical regulatory approvals for its Kendrick Project in Wyoming, paving the way for uranium recovery operations and advancing its broader Lance Projects development strategy.